EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Biomerica's enterprise value is $7.75 Mil.
Biomerica's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was $5.41 Mil. Therefore, Biomerica's EV-to-Revenue for today is 1.43.
The historical rank and industry rank for Biomerica's EV-to-Revenue or its related term are showing as below:
BMRA'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.59 Med: 3.01 Max: 17.02
Current: 1.43
During the past 13 years, the highest EV-to-Revenue of Biomerica was 17.02. The lowest was 0.59. And the median was 3.01.
BMRA's EV-to-Revenue is ranked better than 73.42% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs BMRA: 1.43
As of today (2024-04-23), Biomerica's stock price is $0.7256.
Biomerica's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was $0.32. Therefore, Biomerica's PS Ratio for today is 2.25.
Biomerica EV-to-Revenue Historical Data
The historical data trend for Biomerica's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Biomerica Annual Data
Trend
May14
May15
May16
May17
May18
May19
May20
May21
May22
May23
EV-to-Revenue
4.05
10.33
5.88
2.15
2.70
Biomerica Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
EV-to-Revenue
3.59
2.70
2.69
1.72
2.97
Competitive Comparison
For the Medical Devices subindustry, Biomerica's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomerica EV-to-Revenue Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Biomerica's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Biomerica's EV-to-Revenue falls into.
Biomerica's current Enterprise Value is $7.75 Mil.
Biomerica's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.41 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomerica's share price for today is $0.7256.
Biomerica's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biomerica EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Biomerica's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BMRA has been successfully added to your 